News from NORD

Presentation Chronicles Pathway to Erdheim-Chester Diagnosis


 

At the American College of Rheumatology’s Clinicopathologic Conference, a team of four physicians from the National Institutes of Health and George Washington University presented a case study of a rare inflammatory disease and the series of imaging and pathology tests they conducted to arrive at the diagnosis of Erdheim-Chester disease.

Recommended Reading

Actemra may reduce scleroderma skin thickening
MDedge Rheumatology
VIDEO: TNF inhibitors improved refractory skin disease in juvenile dermatomyositis
MDedge Rheumatology
Benefits, challenges emerge in evolution of rheumatology-dermatology clinics
MDedge Rheumatology
Study evaluates Zika syndrome with joint contractures
MDedge Rheumatology
SHARE initiative releases consensus-based JDM management recommendations
MDedge Rheumatology
Tips on how to differentiate CLE from dermatomyositis
MDedge Rheumatology
Be alert for dermatomyositis without muscle disease
MDedge Rheumatology
Canakinumab controls periodic fever syndromes in post-flare and maintenance dosing
MDedge Rheumatology
ADDRESS II study: Atacicept shows promise for SLE
MDedge Rheumatology
Myeloablative HSCT bests IV CYC for systemic scleroderma
MDedge Rheumatology